How big of a cohort is required to validate (or not) these N=1, (these referring to complete molecular remission seen earlier) observations? So far these have not budged market skepticism that seems on wanting to see magical results.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.